reports
- GlobalData Healthcare Department
BIND Therapeutics Inc (BIND) - Pharmaceuticals & Healthcare - Deals an...
Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established chemotherapeutic agent, docetaxel. It provides AZD-2811, targeted kinase inhibitor, bind-267, and bind-787. BIND Therapeutics also develops oligonucleotides, immuno-oncology, tam targeting, and GC-C....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.